1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow ADVAIR DISKUS: new trials by email Literature Review of ADVAIR DISKUS trials Research Report on ADVAIR DISKUS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS® in Healthy Volunteers Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg, ADVAIR DISKUS - Bioequivalence | Phase 1 | Completed | Respirent Pharmaceuticals Co Ltd. | 34 | 2018-11-20 | 2018-12-28 |
Respirent Pharmaceuticals Co Ltd. (1)
Greece (1)
Chrysoula Doxani, MD, MSc, PhD (1) · Ioannis Stefanidis, Professor (1)